Login with your work email address to view charts. No credit card required.
| Art Unit: | 1629 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1620 — Biomedicinal Chemistry |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 424 — Drug, bio-affecting and body treating compositions 544 — Organic compounds -- part of the class 532-570 series 558 — Organic compounds -- part of the class 532-570 series 604 — Surgery 540 — Organic compounds -- part of the class 532-570 series 548 — Organic compounds -- part of the class 532-570 series 568 — Organic compounds -- part of the class 532-570 series 435 — Chemistry: molecular biology and microbiology 206 — Special receptacle or package |
| Phone: | (571) 270-7020 |
| Email: | ibrahim.bori@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Gen Chem |
| Service: | 15 years |
| Grade: | GS-13 |
| 3-Year Grant rate: | 8% over 1258 cases |
|---|---|
| Difficulty: | Extremely Hard |
| Difficulty Percentile: | 96th
|
With Examiner Bori, you have a 8% chance of getting an issued patent by 3 years after the first office action. Examiner Bori is an extremely hard examiner and in the 96th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Bori, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Bori's grant rate is lower than that of Art Unit 1629 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Bori | 1.8 |
| Art Unit 1629 | 1.3 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.